TNG908

· Tango Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TNG908, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors [Phase 1, Phase 2]